HEADER VIRAL PROTEIN 11-SEP-20 7K3G TITLE SARS-COV-2 ENVELOPE PROTEIN TRANSMEMBRANE DOMAIN: PENTAMERIC STRUCTURE TITLE 2 DETERMINED BY SOLID-STATE NMR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENVELOPE SMALL MEMBRANE PROTEIN; COMPND 3 CHAIN: A, B, C, D, E; COMPND 4 SYNONYM: SM PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: E, 4; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS VIROPORIN, PENTAMERIC ION CHANNEL, TRANSMEMBRANE DOMAIN, VIRAL KEYWDS 2 PROTEIN EXPDTA SOLID-STATE NMR NUMMDL 10 AUTHOR V.S.MANDALA,M.HONG,M.J.MCKAY,A.S.SHCHERBAKOV,A.J.DREGNI REVDAT 7 15-MAY-24 7K3G 1 REMARK REVDAT 6 14-JUN-23 7K3G 1 REMARK REVDAT 5 16-DEC-20 7K3G 1 JRNL REVDAT 4 25-NOV-20 7K3G 1 JRNL REVDAT 3 28-OCT-20 7K3G 1 JRNL REVDAT 2 21-OCT-20 7K3G 1 REMARK HELIX ATOM REVDAT 1 30-SEP-20 7K3G 0 JRNL AUTH V.S.MANDALA,M.J.MCKAY,A.A.SHCHERBAKOV,A.J.DREGNI, JRNL AUTH 2 A.KOLOCOURIS,M.HONG JRNL TITL STRUCTURE AND DRUG BINDING OF THE SARS-COV-2 ENVELOPE JRNL TITL 2 PROTEIN TRANSMEMBRANE DOMAIN IN LIPID BILAYERS. JRNL REF NAT.STRUCT.MOL.BIOL. V. 27 1202 2020 JRNL REFN ESSN 1545-9985 JRNL PMID 33177698 JRNL DOI 10.1038/S41594-020-00536-8 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.HONG,V.MANDALA,M.MCKAY,A.SHCHERBAKOV,A.DREGNI,A.KOLOCOURIS REMARK 1 TITL STRUCTURE AND DRUG BINDING OF THE SARS-COV-2 ENVELOPE REMARK 1 TITL 2 PROTEIN IN PHOSPHOLIPID BILAYERS. REMARK 1 REF RES SQ 2020 REMARK 1 REFN ESSN 2693-5015 REMARK 1 PMID 32995764 REMARK 1 DOI 10.21203/RS.3.RS-77124/V1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH 2.47 REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7K3G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1000251802. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 7.5 REMARK 210 IONIC STRENGTH : 20 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 0.1 MG/UL [U-13C; U-15N] SARS REMARK 210 -COV-2 ENVELOPE PROTEIN REMARK 210 TRANSMEMBRANE DOMAIN, 0.23 MG/UL REMARK 210 POPC, 0.1 MG/UL POPE, 0.08 MG/UL REMARK 210 BOVINE PI, 0.04 MG/UL POPS, 0.04 REMARK 210 MG/UL CHOLESTEROL, AQUEOUS REMARK 210 BUFFER; 0.1 MG/UL [U-13C; U-15N] REMARK 210 SARS-COV-2 ENVELOPE PROTEIN REMARK 210 TRANSMEMBRANE DOMAIN, 0.1 MG/UL REMARK 210 [4-19F-PHE] FLUORO SARS-COV-2 REMARK 210 ENVELOPE PROTEIN TRANSMEMBRANE REMARK 210 DOMAIN, 0.23 MG/UL POPC, 0.1 MG/ REMARK 210 UL POPE, 0.08 MG/UL BOVINE PI, REMARK 210 0.04 MG/UL POPS, 0.04 MG/UL REMARK 210 CHOLESTEROL, AQUEOUS BUFFER; 0.1 REMARK 210 MG/UL [U-15N] 15N SARS-COV-2 REMARK 210 ENVELOPE PROTEIN TRANSMEMBRANE REMARK 210 DOMAIN, 0.1 MG/UL [U-13C] 13C REMARK 210 SARS-COV-2 ENVELOPE PROTEIN REMARK 210 TRANSMEMBRANE DOMAIN, 0.23 MG/UL REMARK 210 POPC, 0.1 MG/UL POPE, 0.08 MG/UL REMARK 210 BOVINE PI, 0.04 MG/UL POPS, 0.04 REMARK 210 MG/UL CHOLESTEROL, AQUEOUS BUFFER REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D CC CORD; 2D NCA/NCO SPEC-CP; REMARK 210 3D NCACX/NCOCX/CONCA; 1D/2D 13C- REMARK 210 19F REDOR; 2D 13C-19F SPEC-CP; REMARK 210 2D NHHC REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ; 800 MHZ; 60 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE NEO; AVANCE II; AVANCE REMARK 210 III HD REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRFAM-SPARKY, TOPSPIN, X-PLOR REMARK 210 NIH 2.47 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 192 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 217 REMARK 217 SOLID STATE NMR STUDY REMARK 217 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLID REMARK 217 STATE NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 217 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 217 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LEU A 37 -81.44 63.73 REMARK 500 1 LEU B 37 -81.49 63.73 REMARK 500 1 LEU C 37 -81.37 63.65 REMARK 500 1 LEU D 37 -81.58 63.85 REMARK 500 1 LEU E 37 -81.54 63.77 REMARK 500 2 LEU A 21 -18.60 -49.12 REMARK 500 2 LEU A 37 -171.09 66.61 REMARK 500 2 LEU B 21 -18.51 -49.54 REMARK 500 2 LEU B 37 -171.09 66.60 REMARK 500 2 LEU C 21 -18.46 -49.59 REMARK 500 2 LEU C 37 -171.17 66.61 REMARK 500 2 LEU D 21 -18.70 -49.08 REMARK 500 2 LEU D 37 -171.12 66.62 REMARK 500 2 LEU E 21 -19.62 -47.43 REMARK 500 2 LEU E 37 -171.12 66.58 REMARK 500 3 THR A 9 -42.37 -136.23 REMARK 500 3 LEU A 37 -70.75 72.67 REMARK 500 3 THR B 9 -42.50 -136.21 REMARK 500 3 LEU B 37 -70.74 72.64 REMARK 500 3 THR C 9 -42.30 -136.29 REMARK 500 3 LEU C 37 -70.66 72.60 REMARK 500 3 THR D 9 -42.44 -136.25 REMARK 500 3 LEU D 37 -70.65 72.67 REMARK 500 3 THR E 9 -42.44 -136.28 REMARK 500 3 LEU E 37 -70.74 72.61 REMARK 500 4 LEU A 37 114.40 64.23 REMARK 500 4 LEU B 37 114.35 64.13 REMARK 500 4 LEU C 37 114.37 64.12 REMARK 500 4 LEU D 37 114.33 64.13 REMARK 500 4 LEU E 37 114.38 64.10 REMARK 500 5 LEU A 37 64.44 62.74 REMARK 500 5 LEU B 37 64.49 62.65 REMARK 500 5 LEU C 37 64.54 62.69 REMARK 500 5 LEU D 37 64.48 62.66 REMARK 500 5 LEU E 37 64.36 62.78 REMARK 500 6 THR A 9 30.06 -160.54 REMARK 500 6 LEU A 21 -19.15 -49.70 REMARK 500 6 THR B 9 30.10 -160.50 REMARK 500 6 LEU B 21 -18.97 -49.95 REMARK 500 6 THR C 9 30.03 -160.52 REMARK 500 6 LEU C 21 -19.02 -49.88 REMARK 500 6 THR D 9 30.13 -160.54 REMARK 500 6 LEU D 21 -19.02 -49.75 REMARK 500 6 THR E 9 30.12 -160.58 REMARK 500 6 LEU E 21 -19.19 -49.91 REMARK 500 7 LEU A 37 150.91 62.55 REMARK 500 7 LEU B 37 150.89 62.50 REMARK 500 7 LEU C 37 151.05 62.53 REMARK 500 7 LEU D 37 151.06 62.54 REMARK 500 7 LEU E 37 151.25 62.40 REMARK 500 REMARK 500 THIS ENTRY HAS 66 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30795 RELATED DB: BMRB REMARK 900 SARS-COV-2 ENVELOPE PROTEIN TRANSMEMBRANE DOMAIN: PENTAMERIC REMARK 900 STRUCTURE DETERMINED BY SOLID-STATE NMR DBREF 7K3G A 8 38 UNP P0DTC4 VEMP_SARS2 8 38 DBREF 7K3G B 8 38 UNP P0DTC4 VEMP_SARS2 8 38 DBREF 7K3G C 8 38 UNP P0DTC4 VEMP_SARS2 8 38 DBREF 7K3G D 8 38 UNP P0DTC4 VEMP_SARS2 8 38 DBREF 7K3G E 8 38 UNP P0DTC4 VEMP_SARS2 8 38 SEQRES 1 A 31 GLU THR GLY THR LEU ILE VAL ASN SER VAL LEU LEU PHE SEQRES 2 A 31 LEU ALA PHE VAL VAL PHE LEU LEU VAL THR LEU ALA ILE SEQRES 3 A 31 LEU THR ALA LEU ARG SEQRES 1 B 31 GLU THR GLY THR LEU ILE VAL ASN SER VAL LEU LEU PHE SEQRES 2 B 31 LEU ALA PHE VAL VAL PHE LEU LEU VAL THR LEU ALA ILE SEQRES 3 B 31 LEU THR ALA LEU ARG SEQRES 1 C 31 GLU THR GLY THR LEU ILE VAL ASN SER VAL LEU LEU PHE SEQRES 2 C 31 LEU ALA PHE VAL VAL PHE LEU LEU VAL THR LEU ALA ILE SEQRES 3 C 31 LEU THR ALA LEU ARG SEQRES 1 D 31 GLU THR GLY THR LEU ILE VAL ASN SER VAL LEU LEU PHE SEQRES 2 D 31 LEU ALA PHE VAL VAL PHE LEU LEU VAL THR LEU ALA ILE SEQRES 3 D 31 LEU THR ALA LEU ARG SEQRES 1 E 31 GLU THR GLY THR LEU ILE VAL ASN SER VAL LEU LEU PHE SEQRES 2 E 31 LEU ALA PHE VAL VAL PHE LEU LEU VAL THR LEU ALA ILE SEQRES 3 E 31 LEU THR ALA LEU ARG HELIX 1 AA1 GLY A 10 LEU A 19 1 10 HELIX 2 AA2 LEU A 21 LEU A 37 1 17 HELIX 3 AA3 GLY B 10 LEU B 19 1 10 HELIX 4 AA4 LEU B 21 LEU B 37 1 17 HELIX 5 AA5 GLY C 10 LEU C 19 1 10 HELIX 6 AA6 LEU C 21 LEU C 37 1 17 HELIX 7 AA7 GLY D 10 LEU D 19 1 10 HELIX 8 AA8 LEU D 21 LEU D 37 1 17 HELIX 9 AA9 GLY E 10 LEU E 19 1 10 HELIX 10 AB1 LEU E 21 LEU E 37 1 17 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1